Stoke Therapeutics
STOK
STOK
106 hedge funds and large institutions have $1.49B invested in Stoke Therapeutics in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less call options, than puts
Call options by funds: $3M | Put options by funds: $4.46M
38% less capital invested
Capital invested by funds: $2.39B → $1.49B (-$902M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
106
Holding in Top 10
1
Calls
$3M
Puts
$4.46M
Top Buyers
| 1 | +$12.2M | |
| 2 | +$8M | |
| 3 | +$5.85M | |
| 4 |
Two Sigma Investments
New York
|
+$3.98M |
| 5 |
RI
RTW Investments
New York
|
+$3.88M |
Top Sellers
| 1 | -$28.1M | |
| 2 | -$7.96M | |
| 3 | -$7.82M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$5.52M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.91M |